Pfizer Inc. (PFE) News
Filter PFE News Items
PFE News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
PFE News Highlights
- PFE's 30 day story count now stands at 35.
- Over the past 22 days, PFE's stories per day has been in a clear uptrend, growing by about 0.10 per 1278 mins.
- AMP, LI and DRUG are the most mentioned tickers in articles about PFE.
Latest PFE News From Around the Web
Below are the latest news stories about PFIZER INC that investors may wish to consider to help them evaluate PFE as an investment opportunity.
The 500 Top Stocks to Buy for 2024, Ranked by AIThese are the very best stocks to buy for 2024 for any investor, according to Tom Yeung's MarketMasterAI system. |
Top Performers: 7 High-Efficiency Stocks With Stellar Profit Per Employee RatiosInundated with myriad ways of assessing publicly traded companies, one unique metric could intrigue investors seeking opportunities in 2024 and that would be high-efficiency stocks. |
Interested in the Weight-Loss Market? Here's 1 Stock to Buy Hand Over Fist in 2024, and 1 to Avoid Like the Plague.While Novo Nordisk dominates the weight-loss market, there are two other stocks to consider as well. |
S&P 500 Is Nearing a Record High. This Could Derail It in 2024.Microsoft and OpenAI are sued by the New York Times for copyright infringement, Amazon plans to launch adverts on Prime Video next month, and other news to start your day. |
Could Pfizer Be a No-Brainer Stock to Buy Right Now, Even If Its COVID Sales Continue to Plunge?COVID-19 products Comirnaty and Paxlovid are no longer Pfizer's crown jewels. But that's OK. |
15 Best Stocks to Buy in 2024 According to Billionaire D.E. ShawIn this article, we looked at D.E. Shaw’s investment philosophy and returns. We also reviewed D.E. Shaw’s 15 best stocks to buy in 2024. You can skip our detailed discussion of D.E. Shaw and go straight to 5 Best Stocks to Buy in 2024 According to Billionaire D.E. Shaw. D.E. Shaw’s multi-strategy hedge fund, known […] |
Healthcare Heroes: 3 Stocks Innovating in Medicine and WellnessDiscover these innovative healthcare stocks, backed by the U.S.'s $4.3 trillion health investment, offering stability and high returns. |
The Next Bull Run: 3 Stocks Poised for Unprecedented Growth in 2024Are you looking for the next bull run in the stock market? |
Pfizer (PFE) Surpasses Market Returns: Some Facts Worth KnowingIn the most recent trading session, Pfizer (PFE) closed at $28.61, indicating a +0.7% shift from the previous trading day. |
Moderna and Pfizer Stock Tumbled in 2023. Wall Street Sees a Rebound.Covid-19-vaccine makers Moderna and Pfizer saw shares drop in 2023, but analysts expect double-digit-percentage gains next year. |